IVVD Stock Analysis: Buy, Sell, or Hold?
IVVD - Invivyd, Inc. Common Stock
$0.83
-0.11 (-11.87%)
▼
5d:
-4.86%
30d:
-19.42%
90d:
-35.66%
BUY
HIGH Confidence
Analysis Updated: Jul 8, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When IVVD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called IVVD this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: IVVD shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: IVVD shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: IVVD is currently trading at $0.83, which is considered slightly low relative to its 30-day fair value range of $0.84 to $1.05.
Technical Outlook: Technically, IVVD is in a strong downtrend. The price is currently testing key support at $0.81. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 11.9% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.00 (+961.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, IVVD is in a strong downtrend. The price is currently testing key support at $0.81. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 11.9% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.00 (+961.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.84 -
$1.05
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-11.9%)
- BULLISH: Trading 961.8% below Wall St target ($10.00)
Trading Range Analysis
30-Day Trading Range
$0.84 -
$1.05
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.81
Resistance Level
$1.00
Current Trend
Strong Downtrend
Technical data as of
Jul 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.62
Wall Street Target
$10.00
(+961.8%)
Revenue Growth (YoY)
21.6%
Profit Margin
-138.9%
Share & Embed Analysis
Last updated: July 08, 2026 4:47 PM ET
Data refreshes hourly during market hours. Next update: 5:47 PM
Data refreshes hourly during market hours. Next update: 5:47 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IVVD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
10
Sells
Net
INSIDERS SELLING
Recent Transactions
Julie Green
SELL
20964 shares
2026-02-18
Robert D Allen III
SELL
19392 shares
2026-02-18
Timothy Edward Lee
SELL
20964 shares
2026-02-18
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 61 BUY |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 55 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 61 BUY |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$111 | 62 BUY |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 59 HOLD |
